Results
1 -
10 of
29Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755, Journal of Neural Transmission Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions, Journal of Neural Transmission / General Section JNT Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice, Journal of Neural Transmission / General Section JNT A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice, Journal of Neural Transmission / General Section JNT [3H]Acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra, Naunyn-Schmiedeberg's Archives of Pharmacology The Effects of NMDA Antagonists on Intracranial Pressure in a Model of Acute Subdural Haematoma in the Rat, Intracranial Pressure VIII Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice, Naunyn-Schmiedeberg's Archives of Pharmacology Cerebral Oedema Following Intracerebral Haemorrhage: the Effect of the NMDA Receptor Antagonists MK-801 and D-CPPene, Brain Edema IX Do N-methyl-D-aspartate Antagonists Have Disproportionately Greater Effects on Brain Swelling than on Ischemic Damage in Focal Cerebral Infarction?, Brain Edema IX Excitotoxicity, Cerebral Ischemia, and Neuroprotection by Competitive NMDA Receptor Antagonists, Emerging Strategies in Neuroprotection